Quick links

Sustainability at Fresenius Kabi

We act today for a better tomorrow

At Fresenius Kabi, sustainability is a responsibility we take seriously. We act today for a better tomorrow. We are committed to making a positive and lasting impact – on our patients, our employees, our planet.

But why does sustainability matter to us? How does it shape our business today and long-term? And how are we turning our ambitions into reality?

Fresenius Kabi trucks at logistic hub Friedberg, Germany
Fresenius Kabi logistics center in Friedberg, Germany

Why sustainability matters

At Fresenius Kabi, we are committed to making a positive and lasting impact - on our patients, our employees, our planet. This is also reflected in one of our Fresenius Principles: We act today for a better tomorrow.

That means:

  • Developing our products in a responsible way - with both patient safety and environmental protection in mind.
  • Reducing our carbon footprint, increasing resource efficiency, and offering our employees the best possible working environment.
  • And acting with integrity and responsibility in everything we do.

We have set ourselves ambitious sustainability targets, are continuously working to improve our performance - and we are not stopping here.

Take a moment to explore the sustainability achievements we have shared on this website, regarding our patients, employees, and a healthy planet. Let’s keep working together - for a healthier, more sustainable future.

Do you have questions about our approach to sustainability or want to learn more about how we are making a difference? Please use our contact form for sustainability-related inquiries. 

Axel Faupel, Head of Sustainability at Fresenius Kabi
Sustainability matters. And for us, it goes hand in hand with economic success. Our approach to improve global health calls for a respectful, innovative, and sustainable way of using our planet’s resources.

Our sustainability approach and ambitions

We are committed to continuously advancing our sustainability efforts, aligning with market demands, and making an impact on society and our planet.

Our sustainability ambition serves as the group-wide strategic framework for integrating environmental, social, and governance (ESG) considerations into our operations. This framework guides our daily actions and shapes how we integrate sustainability into our business.

Sustainability dimensions: Diagram with sections: Committed to Life, Human Dimension, Planet Dimension, and Our Ethical Foundation.

Committed to Life

Human Dimension


Enhancing patient health and well-being: We offer healthcare products that improve the health and well-being of patients.

Enabling access to healthcare worldwide: We strive to break down healthcare barriers and improve access to essential medicines and treatments. We work to increase the accessibility and affordability of healthcare products, supporting more equitable healthcare globally. 

Empowering our employees: We champion a supportive workplace by offering training programs, fair compensation, and promoting a healthy work-life balance.

Planet Dimension


Protecting the environment and saving resources: We are committed to minimizing our ecological footprint. Through innovative sustainability projects, we aim to reduce emissions, cut water consumption at our production sites, and drive resource use.

Fostering innovation: Sustainability drives innovation at Fresenius Kabi – in our products, processes, and long-term environmental performance. By investing in a continuously improvement of our infrastructure and digitalizing our sustainability processes, we create value for our business and stakeholders.

Ethical Foundation


Fostering responsibility across our supply chain: We uphold integrity, transparency, and accountability across all operations. Our commitment to ethical conduct and compliance promotes fair business practices and advances human rights through ongoing engagement and diligence.

We measure what we care for

50% Scope 1 and 2 emission reduction by 2030

About our climate targets

20% process water reduction in water stress areas by 2030

About our water target

20% increase in annual training hours per employee by 2030

Our workforce development

4.33 Employer Engagement Index in 2024 (Fresenius Group) 

About our employee participation

20% LTIFR reduction compared to previous year

About our safety and care culture

< 2.3 Audit & inspection score in 2024 

Quality monitoring efforts

Shaping sustainability in the future 

While we have made strides toward more sustainable operations, there is still work to be done. We will continue pushing forward with ambitious objectives that elevate patient care and broaden access to healthcare.

Our targets, measures, and progress are detailed on the following pages. We invite you to explore and join us on this journey toward a more sustainable future.

Improving lives through access, education, and support

At Fresenius Kabi, our mission “Committed to Life” drives  everything we do. We are dedicated to advancing global health by prioritizing patient well-being and empowering employees.

Providing access to affordable, high-quality healthcare

We are committed to improving patients' quality of life worldwide by providing access to high-quality, affordable medicines and innovative healthcare solutions. Our growing portfolio includes pharmaceuticals - generics and biosimilars - that offer cost-effective alternatives to originator drugs, and our MedTech and Nutrition products that establish a solid foundation for patient care and recovery. 

In 2024 our products reached 450 million patients – 200 million patients in Europe alone.

Strengthening supply chains to enhance patient care

Ensuring that our products are available is vital to patient care. We continuously invest in our global manufacturing network to maintain a reliable and resilient supply of life-saving therapies. By strengthening our supply infrastructure, we help to prevent disruptions and enhance healthcare delivery worldwide.  

Angels for Change: Commitment against drug shortages

Angels for Change is taking a strong stand in the fight against drug shortages: The pilot initiative "Project GOLD" (Generic Oncology Lifesaving Drugs), is establishing a resilient supply of six essential cancer medications. Angels for Change Together with other partners Fresenius will create an emergency reserve to ensure that physicians can provide patients with necessary medications  and stable care even in critical situations.

Additionally, Fresenius Kabi USA was honored with the "2024 Drug Shortage Guardian Award."
The company stood out for its outstanding efforts during the chemotherapy shortage of 2023. Karen Twardzik and Danielle Gross, two Fresenius employees, also received individual awards for their extraordinary support in critical supply situations. Their leadership and tireless work exceeded their normal responsibilities, ensuring life-saving medicines reached patients in need, even during dire shortages.

Angels for Change remains a driving force, supported by groundbreaking projects like Project GOLD and close collaboration with stakeholders in the pharmaceutical supply chain.

Fresenius Kabi Angels for Change Award 2024

Expanding our social impact by promoting research and medical education

Health education is a fundamental aspect of our commitment, as we provide healthcare professionals, caregivers and patients with the knowledge to make informed decisions and achieve better health outcomes. Through awareness campaigns, and community engagement, we actively contribute to advancing science and public health.

Combating disease-related malnutrition with clinical nutrition

Fresenius Kabi offers a wide range of clinical nutrition products to address malnutrition and cater to the specific needs of vulnerable patients, including those with cancer or critical illnesses. The company conducts extensive research, participating in around 30 studies and supporting scientific advancements through the JUMPStart program and partnerships like the ESICM Fresenius Kabi Clinical Nutrition Award. In 2024, the award recognized a groundbreaking study on the effects of cyclical enteral nutrition and ketogenic fasting on postoperative delirium, emphasizing the importance of aligning nutrition with the body’s natural rhythms to improve patient outcomes. This innovative approach reflects Fresenius Kabi’s commitment to enhancing care and advancing medical education.

About United for Clinical Nutrition
Nutrition – the key to human health

Sustainability in our value chain

Find out where sustainability aspects play a role at our production sites, for example in the manufacturing of infusion solutions. 

Disclaimer

Fresenius Kabi is a fully consolidated subsidiary of Fresenius SE. This website includes an overview of the Fresenius Kabi sustainability commitment. All data on this website corresponds to a subset of group data that is published in the Fresenius Group Sustainability Statement 2024 and thus is assured by an external auditor. The Sustainability Statement is prepared in full compliance with the European Sustainability Reporting Standards (ESRS).